Dimenhydrinate
Back to searchMolecule Structure
Scientific Name
Dimenhydrinate
Description of the Drug
Dimenhydrinate is a medication used to prevent and treat nausea, vomiting, vertigo, and motion sickness.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00985
http://www.drugbank.ca/drugs/DB00985
Brand Name(s)
Antemin, Dimenhydrinate, Dramamine, Vertigo-vomex s
Company Owner(s)
Heather Drug Co Inc, Fresenius Kabi Usa Llc, Wyeth Ayerst Laboratories, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Baxter Healthcare Corp Anesthesia And Critical Care, Watson Laboratories Inc, Alra Laboratories Inc, Nexgen Pharma Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL5128 | |
| DrugBank | DB00985 | |
| PubChem: Thomson Pharma | 15356136 | |
| PubChem | 10660 | |
| LINCS | LSM-6066 | |
| EPA CompTox Dashboard | DTXSID9025087 | |
| ChemicalBook | CB4308768 | |
| rxnorm | DIMENHYDRINATE | DRAMAMINE |
| ChEBI | 94848 |
